Casdin Capital »

Intellia Therapeutics shares owned by Casdin Capital

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Casdin Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $44M 1.5M 30.49
2023-09-30 $37M 1.2M 31.62
2023-06-30 $52M 1.3M 40.78
2023-03-31 $48M 1.3M 37.27
2022-12-31 $10M 295k 34.89
2022-09-30 $17M 295k 55.96